ATE1906T1 - Glucosamin-peptid-derivate, ihre herstellung und verwendung. - Google Patents

Glucosamin-peptid-derivate, ihre herstellung und verwendung.

Info

Publication number
ATE1906T1
ATE1906T1 AT80100811T AT80100811T ATE1906T1 AT E1906 T1 ATE1906 T1 AT E1906T1 AT 80100811 T AT80100811 T AT 80100811T AT 80100811 T AT80100811 T AT 80100811T AT E1906 T1 ATE1906 T1 AT E1906T1
Authority
AT
Austria
Prior art keywords
hydrogen
lower alkyl
substituted
peptide derivatives
preparation
Prior art date
Application number
AT80100811T
Other languages
English (en)
Inventor
Yuichi Yamamura
Ichiro Hokko-Komuinshukusha 76 Azuma
Higashi-Ku
Kobayashi Shigeru
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Application granted granted Critical
Publication of ATE1906T1 publication Critical patent/ATE1906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT80100811T 1979-02-21 1980-02-18 Glucosamin-peptid-derivate, ihre herstellung und verwendung. ATE1906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1992979A JPS55111499A (en) 1979-02-21 1979-02-21 Glucosamine derivative and its preparation
EP80100811A EP0014984B1 (de) 1979-02-21 1980-02-18 Glucosamin-Peptid-Derivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE1906T1 true ATE1906T1 (de) 1982-12-15

Family

ID=12012904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80100811T ATE1906T1 (de) 1979-02-21 1980-02-18 Glucosamin-peptid-derivate, ihre herstellung und verwendung.

Country Status (6)

Country Link
US (1) US4369178A (de)
EP (1) EP0014984B1 (de)
JP (1) JPS55111499A (de)
AT (1) ATE1906T1 (de)
CA (1) CA1239636A (de)
DE (1) DE3061175D1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
JPS57144225A (en) * 1981-03-04 1982-09-06 Tadao Kokubu Antigenetic preparation for treating nonspecific allergic diseases and its preparation
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
FI852105L (fi) * 1984-05-29 1985-11-30 Ciba Geigy Ag Acylerade sockerderivat, foerfarande foer deras framstaellning och deras anvaendning.
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
JPH0625067B2 (ja) * 1986-05-13 1994-04-06 全国農業協同組合連合会 子豚の離乳後下痢の感染防止法
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
JPH0724834Y2 (ja) * 1988-07-06 1995-06-05 株式会社大興電機製作所 回線との接続状態を表示する端末装置
US5256646A (en) * 1990-07-27 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4224V
CA2593749A1 (en) * 2005-02-04 2006-08-10 Alchemia Limited Classes of compounds that interact with integrins
WO2006131023A1 (en) * 2005-06-08 2006-12-14 Newbiomed Pika Pte Ltd Polyinosinic acid-polycytidylic acid-based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
FR2900150B1 (fr) * 2006-04-25 2012-07-06 Fluofarma Composes de type 1,4-naphtoquinones, compositions les comprenant et utilisation de ces composes en tant qu'agent anti-cancereux
GB2458473A (en) * 2008-03-17 2009-09-23 Imuthes Ltd 3'-O-allyl- and 3'-O-carboxymethyl- 2'-aminosaccharide derivatives, & amides thereof with peptides, as adjuvants
WO2014043792A1 (en) * 2012-09-19 2014-03-27 Fahkreddin Jamali Glucosamine pro-drugs
RU2678981C2 (ru) 2014-12-23 2019-02-05 Йишенг Байофарма (Сингапур) Пте Лтд Композиция от бешенства, содержащая адъювант pika
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
DE2862107D1 (en) * 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes

Also Published As

Publication number Publication date
EP0014984A1 (de) 1980-09-03
JPS6244555B2 (de) 1987-09-21
US4369178A (en) 1983-01-18
EP0014984B1 (de) 1982-12-01
DE3061175D1 (en) 1983-01-05
CA1239636A (en) 1988-07-26
JPS55111499A (en) 1980-08-28

Similar Documents

Publication Publication Date Title
ATE1906T1 (de) Glucosamin-peptid-derivate, ihre herstellung und verwendung.
KR850004757A (ko) 치환 트란스-1, 2-디아미노싸이클로헥실 아미드 화합물의 제법
ES422395A1 (es) Un procedimiento para la preparacion de cinamamidas e hi- drocinamamidas.
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
ES442845A2 (es) Procedimiento para la preparacion de nuevos derivados de la n-(trimetoxi-3,4,5 cinnamoil)piperazina.
GR76356B (de)
IL72166A (en) Beta-carboline dicarboxylic acid derivatives and pharmaceutical compositions containing the same
ES488370A0 (es) Un procedimiento para la preparacion de derivados de 2-hidroxinaftaleno.
ES8106731A1 (es) Un procedimiento para preparar benzoxazepinas
IE38806L (en) 1,1,3,3 - substituted hydroxyindanes
KR870004038A (ko) 제초제 화합물의 제조방법
ES437842A1 (es) Procedimiento para la preparacion de cefalosporinas.
ES449885A1 (es) Procedimiento para preparar n'-aminoacilaminofenil)-acetami-dinas.
ES435351A1 (es) Procedimiento para preparar 1-(3-fenil-propil)-4-furoilpi- perazinas.
ES441054A1 (es) Procedimiento de preparacion de nuevos derivados tiazolicos organofosforados.
FR2331335B2 (de)
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.
ES441437A1 (es) Procedimiento para la preparacion de crotonanilidas susti- tuidas.
GB1366182A (en) Intermediates useful in the preparation of cephalosporin derivativ es
ES471606A2 (es) Mejoras introducidas en el objeto de la patente principal, num. 450.300, presentada el 30 de julio de 1976, por: proce-dimiento de preparacion de derivados a-fenil-bencilidenicos de aminoacidos
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
GB1467225A (en) 7-alkoxy-4,6-dihydroxy-quinoline derivatives and pharmaceuti cal compositions thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee